Blood analyte sensing using fluorescent dye-loaded red blood cells
暂无分享,去创建一个
Kenith E. Meissner | Sarah C. Ritter | Xiaole Shao | Nicholas Cooley | Mark A. Milanick | Timothy E. Glass | S. Ritter | M. Milanick | K. Meissner | T. Glass | Nicholas P. Cooley | Xiaole Shao
[1] Julie Wagner,et al. Invasiveness as a barrier to self-monitoring of blood glucose in diabetes. , 2005, Diabetes technology & therapeutics.
[2] M. S. Kirkman,et al. Response to Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61 , 2011, Diabetes Care.
[3] L. Machesky,et al. Fluorescent erythrocyte ghosts as standards for quantitative flow cytometry. , 1995, Cytometry.
[4] F. Kuypers,et al. Effect of osmotic lysis and resealing on red cell structure and function. , 1990, The Journal of laboratory and clinical medicine.
[5] R. Flower,et al. Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using ICG-loaded erythrocyte ghost cells. , 2008, Investigative ophthalmology & visual science.
[6] Bruce Buckingham,et al. Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems. , 2010, Endocrinology and metabolism clinics of North America.
[7] V. Basevi. Standards of Medical Care in Diabetes—2011 , 2011, Diabetes Care.
[8] J. M. Lanao,et al. Drug, enzyme and peptide delivery using erythrocytes as carriers. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[9] S. Ritter,et al. Encapsulation of FITC to monitor extracellular pH: a step towards the development of red blood cells as circulating blood analyte biosensors , 2011, Biomedical optics express.
[10] M. Lieber,et al. Dynamics of the holes in human erythrocyte membrane ghosts. , 1982, The Journal of biological chemistry.
[11] M. Magnani,et al. Erythrocyte-based drug delivery , 2005, Expert opinion on drug delivery.
[12] J. Tobias,et al. Continuous pH Monitoring Using the Paratrend® 7 Inserted into a Peripheral Vein in a Patient with Shock and Congenital Lactic Acidosis , 2002, Clinical pediatrics.
[13] Mehrdad Hamidi,et al. Carrier Erythrocytes: An Overview , 2003, Drug delivery.
[14] N. Marsden,et al. Accumulation of Dextran in Human Red Cells after Hæmolysis , 1959, Nature.
[15] A. Carruthers,et al. Facilitated diffusion of glucose. , 1990, Physiological reviews.
[16] Mehrdad Hamidi,et al. Applications of carrier erythrocytes in delivery of biopharmaceuticals. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[17] Mark R. Burge,et al. Continuous Glucose Monitoring: The Future of Diabetes Management , 2008 .
[18] R H Glew,et al. Enzyme loading of erythrocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[19] D. Williamson,et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence , 2010, Population health metrics.
[20] P. Lefevre. EVIDENCE OF ACTIVE TRANSFER OF CERTAIN NON-ELECTROLYTES ACROSS THE HUMAN RED CELL MEMBRANE , 1948, The Journal of general physiology.
[21] M. Abdel-Kader,et al. Mammalian erythrocytes as physiological carriers of fluorescent exogenous agents: a comparative study of bovine and camel red blood cells. , 1995, Artificial organs.
[22] G. Mcgarraugh. The chemistry of commercial continuous glucose monitors. , 2009, Diabetes technology & therapeutics.